Life Transitions

A recent study found overweight status in midlife, compared to normal body mass index, was linked to a higher burden of morbidity and greater proportion of life lived with morbidity.

Astellas announced positive data from its study investigating the long-term safety of fezolinetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.

More than half of postmenopausal women experience female pattern hair loss, according to a cross-sectional study in the journal Menopause.

Risk assessment, lifestyle counseling, adverse effects, and medication management.

According to a recent study, women who experience stable menstrual cycles during the menopause transition have a significantly higher cardiovascular disease (CVD) risk later in life than those who have a late increase in cycle length.

Midlife women with early-stage vision impairment are significantly more likely to develop depressive symptoms, according to a study in the journal Menopause, which used data from the Michigan site of the Study of Women’s Health Across the Nation (SWAN).

A more standardized approach to menopause preparedness, including educating both patients and providers, is needed to improve care and quality of life for individuals during and after menopause, according to a study in the journal Menopause.

Physical inactivity can exacerbate BMD decline and increase fracture risk.

An evaluation of multiple recommended eating patterns has found that intakes of legumes, dietary fiber, and vegetable protein is linked to lower risk of peripheral arterial disease (PAD), whereas intakes of unprocessed red meat, processed meat, and regular soft drinks are associated with higher risk.

The challenge of diagnosis occurs in distinguishing “normal” from “abnormal” in a time of rapid and dynamic change.

A secondary analysis of the Women’s Health Initiative (WHI)-Calcium and Vitamin D (CaD) clinical trial has concluded that vasomotor symptom severity is not linked to any clinical event.

A prospective study of generally healthy perimenopausal women has concluded that low bone mineral density (BMD) is significantly linked with periodontal disease in women over 58 years old, and independent of tobacco consumption or oral hygiene.

Read about the impact when long-acting reversible contraception (LARC) was offered to teenage mothers prior to hospital discharge.

A peak in hot fl ash reports was observed in July, while January had a trough in hot fl ash reports.

The authors noted that, although recent guidelines embrace using history of menopause before age 40 to refine atherosclerotic cardiovascular disease (ASCVD) risk assessments in middle-aged women, “robust data on cardio-vascular disease risk in this population is lacking.”

New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).

Australian researchers believe that PD-L1 may have potential as an indicator of potential response to chemotherapy in women with metastatic breast cancer. That was based on results of a randomized trial, presented at the European Society for Medical Oncology in Lugano, Switzerland.

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.

The timing of postmenopausal hormone therapy (HT) significantly impacts coronary risk and overall benefit-to-risk profile, according to an overview of Women’s Health Initiative (WHI) results in the journal Menopause.

Long-acting reversible contraception (LARC) use among sexually active female adolescents in Rochester, New York, rose from about 4% before a local community intervention to roughly 24% after the initiative.